0001209191-19-057143.txt : 20191119
0001209191-19-057143.hdr.sgml : 20191119
20191119161531
ACCESSION NUMBER: 0001209191-19-057143
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191118
FILED AS OF DATE: 20191119
DATE AS OF CHANGE: 20191119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GARDINER SANDRA A.
CENTRAL INDEX KEY: 0001218574
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37744
FILM NUMBER: 191231354
MAIL ADDRESS:
STREET 1: CUTERA, INC.
STREET 2: 3240 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER NAME:
FORMER CONFORMED NAME: GARDINER SANDRA
DATE OF NAME CHANGE: 20030212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulse Biosciences, Inc.
CENTRAL INDEX KEY: 0001625101
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 465696597
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: 510-906-4600
MAIL ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
FORMER COMPANY:
FORMER CONFORMED NAME: Electroblate, Inc.
DATE OF NAME CHANGE: 20141113
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-18
0
0001625101
Pulse Biosciences, Inc.
PLSE
0001218574
GARDINER SANDRA A.
3957 POINT EDEN WAY
HAYWARD
CA
94545
0
1
0
0
CFO & EVP Admin. and Finance
Stock Option (right to buy)
13.94
2019-11-18
4
A
0
103842
0.00
A
2020-11-18
2029-11-18
Common Stock
103842
103842
D
Stock Option (right to buy)
13.94
2019-11-18
5
A
0
E
103842
0.00
A
2029-11-18
Common Stock
103842
103842
D
The shares subject to the option will vest in equal annual installments over the following four years on the anniversary of the grant date, subject to the Reporting Person's continued service through each vesting date.
The shares subject to the option shall vest based upon the achievement of performance objectives, with vesting targets set no less than one-fourth (1/4) vesting per year upon achievement of said objectives established by the Compensation Committee of the Issuer, subject to the Reporting Person's continued service through each vesting date. If performance objectives are not set by the Compensation Committee, the shares subject to the option will vest in equal annual installments over the following four years on the anniversary of the grant date, subject to the Reporting Person's continued service through each vesting date.
/s/ Darrin R. Uecker, as Attorney-in-Fact
2019-11-19